TP53 and neuroblastoma: (iii) Uncoupling p53 from its negative regulator MDM2 with small molecules competing for the respective docking sites (such as Nutlin-3, MI-63, and RITA among others) should lead to p53 reactivation, a potentially valuable approach to neuroblastoma therapy.